Natural Beauty Bio-Technology Limited (0157.HK)
HKD 0.48
(-1.03%)
HKD 0.48
(-1.03%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 27.54 Million HKD | 260.94% |
| 2022 | -17.11 Million HKD | 71.06% |
| 2021 | -59.13 Million HKD | 28.86% |
| 2020 | -83.12 Million HKD | 3.46% |
| 2019 | -86.11 Million HKD | 52.43% |
| 2018 | -181.02 Million HKD | 37.34% |
| 2017 | -288.9 Million HKD | 32.6% |
| 2016 | -428.63 Million HKD | 14.74% |
| 2015 | -502.72 Million HKD | 13.81% |
| 2014 | -583.28 Million HKD | -14.95% |
| 2013 | -507.4 Million HKD | -17.34% |
| 2012 | -432.44 Million HKD | 22.6% |
| 2011 | -558.73 Million HKD | 2.91% |
| 2010 | -575.48 Million HKD | -2.89% |
| 2009 | -559.34 Million HKD | -2.41% |
| 2008 | -546.2 Million HKD | 7.22% |
| 2007 | -588.74 Million HKD | -65.26% |
| 2006 | -356.24 Million HKD | -5.16% |
| 2005 | -338.74 Million HKD | -43.59% |
| 2004 | -235.92 Million HKD | -38.56% |
| 2003 | -170.26 Million HKD | 21.46% |
| 2002 | -216.77 Million HKD | -192.95% |
| 2001 | -73.99 Million HKD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 60.48 Million HKD | 0.0% |
| 2023 Q2 | 23.62 Million HKD | 0.0% |
| 2023 FY | 27.54 Million HKD | 260.94% |
| 2023 Q4 | 27.54 Million HKD | 0.0% |
| 2022 Q2 | -62.04 Million HKD | 0.0% |
| 2022 Q4 | -17.11 Million HKD | 0.0% |
| 2022 FY | -17.11 Million HKD | 71.06% |
| 2021 Q2 | -57.83 Million HKD | 0.0% |
| 2021 FY | -59.13 Million HKD | 28.86% |
| 2021 Q4 | -59.13 Million HKD | 0.0% |
| 2020 FY | -83.12 Million HKD | 3.46% |
| 2020 Q2 | -44.64 Million HKD | 0.0% |
| 2020 Q4 | -83.12 Million HKD | 0.0% |
| 2019 Q4 | -86.11 Million HKD | 0.0% |
| 2019 FY | -86.11 Million HKD | 52.43% |
| 2019 Q2 | -131.81 Million HKD | 0.0% |
| 2018 Q2 | -320.49 Million HKD | 0.0% |
| 2018 FY | -181.02 Million HKD | 37.34% |
| 2018 Q4 | -181.02 Million HKD | 0.0% |
| 2017 Q4 | -288.9 Million HKD | 0.0% |
| 2017 FY | -288.9 Million HKD | 32.6% |
| 2017 Q2 | -373.04 Million HKD | 0.0% |
| 2016 FY | -428.63 Million HKD | 14.74% |
| 2016 Q2 | -563.77 Million HKD | 0.0% |
| 2016 Q4 | -428.63 Million HKD | 0.0% |
| 2015 Q4 | -502.72 Million HKD | 0.0% |
| 2015 FY | -502.72 Million HKD | 13.81% |
| 2015 Q2 | -648.13 Million HKD | 0.0% |
| 2014 Q4 | -583.28 Million HKD | 0.0% |
| 2014 FY | -583.28 Million HKD | -14.95% |
| 2014 Q2 | -599.55 Million HKD | 0.0% |
| 2013 FY | -507.4 Million HKD | -17.34% |
| 2013 Q4 | -507.4 Million HKD | 0.0% |
| 2013 Q2 | -463.07 Million HKD | 0.0% |
| 2012 FY | -432.44 Million HKD | 22.6% |
| 2012 Q2 | -468.25 Million HKD | 0.0% |
| 2012 Q4 | -432.44 Million HKD | 0.0% |
| 2011 Q2 | -577.09 Million HKD | 0.0% |
| 2011 Q4 | -558.73 Million HKD | 0.0% |
| 2011 FY | -558.73 Million HKD | 2.91% |
| 2010 Q2 | -531.94 Million HKD | 0.0% |
| 2010 FY | -575.48 Million HKD | -2.89% |
| 2010 Q4 | -575.48 Million HKD | 0.0% |
| 2009 Q4 | -559.34 Million HKD | 0.0% |
| 2009 FY | -559.34 Million HKD | -2.41% |
| 2008 FY | -546.2 Million HKD | 7.22% |
| 2007 FY | -588.74 Million HKD | -65.26% |
| 2006 FY | -356.24 Million HKD | -5.16% |
| 2005 FY | -338.74 Million HKD | -43.59% |
| 2004 FY | -235.92 Million HKD | -38.56% |
| 2003 FY | -170.26 Million HKD | 21.46% |
| 2002 FY | -216.77 Million HKD | -192.95% |
| 2001 FY | -73.99 Million HKD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Innovative Pharmaceutical Biotech Limited | 914.37 Million HKD | 96.988% |
| China Overseas Nuoxin International Holdings Limited | 9.99 Million HKD | -175.688% |
| Prosperous Future Holdings Limited | -337.41 Million HKD | 108.163% |
| Huasheng International Holding Limited | 175.03 Million HKD | 84.264% |
| Fourace Industries Group Holdings Limited | -250.33 Million HKD | 111.003% |
| Evergreen Products Group Limited | 430.83 Million HKD | 93.607% |
| EC Healthcare | 1.05 Billion HKD | 97.377% |
| Ming Fai International Holdings Limited | -329.49 Million HKD | 108.36% |
| Blue Moon Group Holdings Limited | -4.18 Billion HKD | 100.658% |
| SuperRobotics Holdings Limited | 126.44 Million HKD | 78.216% |
| Takbo Group Holdings Limited | -175.44 Million HKD | 115.7% |
| Hyfusin Group Holdings Limited | -318.4 Million HKD | 108.651% |